Synthego

Series CBiotechnologyprivate

Genome engineering company providing synthetic RNA and CRISPR tools that accelerate genomic research.

Valuation
$1B
Total Funding
$150M
Stage
Series C
Sector
Biotechnology
Headquarters
Redwood City, CA
CEO
Paul Dabrowski
IPO Status
private

Funding History

Round Amount Date
Series C $100M Mar 2021
Series B $45M Oct 2019
Series A $17M Jun 2017

Track Synthego IPO timeline, funding rounds, investor activity, and valuation on TechStackIPO โ€” the pre-IPO intelligence platform.

Loading company data...